Track this trial free. DataLookout checks ClinicalTrials.gov daily and emails you which fields changed on NCT05585775 (status, enrollment, completion dates, endpoints, sites) when this record is updated. Free accounts track up to 5 trials.

Track this trial

Mood and Thought Process Study

Study acronym: MAT Process
StatusCompleted
PhaseNot applicable
Started
View on ClinicalTrials.gov ↗

Record History

See every version on ClinicalTrials.gov ↗

  1. Primary endpoints: details revised at 1 of 4 entries Show 4 more changesShow less
    • Trial completed
    • Final enrollment: 64 participants (planned 76)
    • Primary completion date changed from estimate of Dec 31, 2026 to Sep 4, 2026
    • Eligibility criteria expanded, about 13 words
  2. Trial status: Recruiting to Active, Not Recruiting
    • Site details revised
    v9
  3. Primary and study completion dates: Dec 2026 to Dec 31, 2026
    • Site contact updated
    v8
  4. Site contact updatedv7
  5. Start date: Dec 1, 2022 to Apr 6, 2023v6
Show 4 earlier versionsHide 4 earlier versions
  1. Eligibility criteria shortened, about 14 wordsv5
  2. Start date changed from estimate of Jan 2023 to Dec 1, 2022
    • Eligibility criteria expanded, about 8 words
    v4
  3. Trial status: Not Yet Recruiting to Recruiting
    • Site details revised
    v3
  4. Start date: Nov 2022 to Jan 2023
    • Primary and study completion dates: Dec 2027 to Dec 2026
    v2
  1. Study First Submitted
  • Stopped: an ongoing trial was terminated, suspended or withdrawn.
  • Notable: the trial’s plan changed such as a big move in its timeline or size, a new primary endpoint, sponsor or phase, or recruiting opened or resumed.
  • Minor: routine progress and housekeeping, such as sites added or enrollment closed.
Butler Hospital
30 trials monitored
See 1 trial at risk
Depression
3,055 trials monitored
See 173 trials at risk
The primary objective for this project is to test whether affective executive functioning is a mechanism of action of mindfulness-based cognitive therapy and Wellness for Wellbeing. The main questions it aims to answer are: 1. Test the effect of MBCT vs. Wellness for Wellbeing on affective inhibition (i.e., emotionally valenced inhibition as measured via the affective Go/No Go task) using an RCT. 2. Test the effect of MBCT vs. Wellness for Wellbeing on (a) affective updating and (b) affective shifting. Outcomes will be measured with the affective n-Back and the affective Internal Switching Task, respectively. 3a) The investigators will examine whether depression symptom severity co-varies with change in affective executive functioning (i.e., affecting inhibition, shifting, and updating) over time. 3b) The investigators will examine whether compliance with treatment protocol (e.g., number of classes attended, amount of home practice) predicts endpoint executive functioning. Participants will complete surveys, interviews, and computer tasks, and will be randomized to either Mindfulness-Based Cognitive Therapy or Wellness for Wellbeing.
Trial Details
NCT Number NCT05585775
Lead Sponsor Butler Hospital
Collaborators: National Center for Complementary and Integrative Health (NCCIH)
Conditions
(from sponsor)		 Depression in Remission, Depressive Symptoms, Depression
Related terms Depression
Enrollment 64 participants
Start Date
Primary Completion (estimated)
Study Completion (estimated)
Updated on ClinicalTrials.gov